Medicare Enrolled
Dr. Patrick Godwin, MD
Internal Medicine · Roxboro, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Godwin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Godwin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Godwin
Dr. Patrick Godwin is an internal medicine specialist in Roxboro, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Godwin performed 3,485 Medicare services across 1,835 unique beneficiaries.
Between the years covered by Open Payments, Dr. Godwin received a total of $3,348 from 44 pharmaceutical and/or device companies across 214 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Godwin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 10% volume in NC
$3,348 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,485
Medicare services
Top 10% in NC for internal medicine
1,835
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~174 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,015 | $83 | $125 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
623 | $60 | $88 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
316 | $118 | $121 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
278 | $10 | $14 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
262 | $48 | $76 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
251 | $1 | $10 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
239 | $71 | $121 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
136 | $90 | $122 |
| Autonomic nervous system testing with heart rate response to deep breathing This test evaluates the function of the autonomic nervous system by measuring how the heart rate changes in response to deep breathing. |
134 | $64 | $82 |
| Annual depression screening | 66 | $16 | $17 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
53 | $36 | $59 |
| Chronic care management services Comprehensive assessment and care planning for patients requiring ongoing chronic care management. |
33 | $37 | $55 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
26 | $150 | $195 |
| Annual alcohol misuse screening, 5 to 15 minutes | 24 | $17 | $17 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
15 | $89 | $124 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
14 | $11 | $18 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$3,348
Total received (2018-2024)
Avg $478/year across 7 years
Top 22% in NC for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
214
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,348 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$571
2023
$569
2022
$386
2021
$352
2020
$310
2019
$333
2018
$827
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$94
Otsuka America Pharmaceutical, Inc.
$89
Lilly USA, LLC
$79
ABBVIE INC.
$69
PFIZER INC.
$56
E.R. Squibb & Sons, L.L.C.
$36
Boehringer Ingelheim Pharmaceuticals, Inc.
$36
Merck Sharp & Dohme LLC
$30
AIMMUNE THERAPEUTICS, INC.
$21
Corium, LLC
$16
Bayer Healthcare Pharmaceuticals Inc.
$16
AstraZeneca Pharmaceuticals LP
$15
GlaxoSmithKline, LLC.
$14
Top 3 companies account for 45.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$450
ABBVIE INC.
$256
Lilly USA, LLC
$255
PFIZER INC.
$247
Boehringer Ingelheim Pharmaceuticals, Inc.
$194
AstraZeneca Pharmaceuticals LP
$187
Amgen Inc.
$155
Janssen Pharmaceuticals, Inc
$150
Otsuka America Pharmaceutical, Inc.
$147
SANOFI-AVENTIS U.S. LLC
$135
E.R. Squibb & Sons, L.L.C.
$133
Takeda Pharmaceuticals U.S.A., Inc.
$109
Merck Sharp & Dohme Corporation
$89
Merck Sharp & Dohme LLC
$72
Novartis Pharmaceuticals Corporation
$49
Cranial Technologies, Inc
$47
Greer Laboratories, Inc.
$42
Shire North American Group Inc
$41
Biohaven Pharmaceuticals, Inc.
$40
Exact Sciences Corporation
$34
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$33
SANOFI PASTEUR INC.
$33
AbbVie Inc.
$32
Xeris Pharmaceuticals, Inc.
$31
Supernus Pharmaceuticals, Inc.
$31
Mylan Specialty L.P.
$29
Purdue Pharma L.P.
$26
GlaxoSmithKline, LLC.
$25
Hikma Pharmaceuticals USA
$25
Allergan, Inc.
$25
Genentech USA, Inc.
$23
AIMMUNE THERAPEUTICS, INC.
$21
Allergan Inc.
$21
Ironshore Pharmaceuticals Inc.
$18
Phadia US Inc.
$16
Corium, LLC
$16
Bayer Healthcare Pharmaceuticals Inc.
$16
Nestle HealthCare Nutrition Inc.
$16
Tactile Systems Technology Inc
$15
Biohaven Pharmaceutical Holding Company Ltd.
$14
IDORSIA PHARMACEUTICALS US INC
$14
Synergy Pharmaceuticals Inc
$13
Amarin Pharma Inc.
$12
ARBOR PHARMACEUTICALS, INC.
$12
Top 3 companies account for 28.7% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · Aimovig · Amitiza · Azstarys · BELSOMRA · BYDUREON · CAMZYOS · CHANTIX · COMIRNATY · Cologuard Collection Kit · DIABETES - DISEASE · Doc Band · ELIQUIS · EMGALITY · ENTRESTO · Edarbi · FARXIGA · FASENRA · FLEXITOUCH · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · GARDASIL · GARDASIL 9 · GARDASIL9 · GVOKE HYPOPEN · GVOKE PFS · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · JORNAY PM · Kerendia · LINZESS · LYRICA · MOUNJARO · MYDAYIS · Mitigare · NUCALA · NURTEC ODT · ORALAIR · Otezla · Ozempic · PAXLOVID · PNEUMOVAX 23 · PREVNAR - 13 · PREVNAR 20 · Prolia · QELBREE · QULIPTA · QUVIVIQ · REXULTI · ROTATEQ · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYMPROIC · Saxenda · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULANCE · TRULICITY · TRUMENBA · Tresiba · Trintellix · Trulance · UBRELVY · VAXELIS · VRAYLAR · VYVANSE · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN · Xofluza · Yupelri · ZENPEP · ZOSTAVAX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
41
Per 100K population
104.4
County median income
$64,927
Nearest hospital
PERSON MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Godwin is a clinical cardiology specialist, with above-average Medicare volume (top 10% in NC), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Godwin experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Godwin performed 1,015 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Godwin receive payments from pharmaceutical companies?
Yes. Dr. Godwin received a total of $3,348 from 44 companies across 214 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Godwin's costs compare to other internal medicine physicians in Roxboro?
Dr. Godwin's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Godwin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Roxboro
Browse internal medicine physicians in Roxboro ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NC
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NC
Which NC internal medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology